Boehringer, Bridge IPF Deal Collapses On Toxicity Concerns

Termination A Setback To Both Companies

Broken deal
Bridge Still Committed To Further Development Of BBT-877 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip